CCR2 and neoplasm: One, three and five days after the removal of the primary tumor, ATs with CD115+ cells from both BL6 and Ccr2-/- mice restored metastasis in Ccr1-/- mice to the same levels as observed in BL6 mice (Fig. 4 B).